AUG 10, 2026 · JOURNAL ARTICLE
Single-cell multiomics identifies an ALDH9A1–carnitine signaling axis driving resistance of NSCLC to immunotherapy
Proceedings of the National Academy of Sciences
Mechanistic discovery in preclinical models with supporting human correlative data, but lacks clinical trial evidence of efficacy in patients with immunotherapy resistance.
Study details
DesignPreclinical mechanistic study with correlat…
InterventionALDH9A1 genetic loss, pharmacological ALDH9…
ComparatorWild-type or control-treated mice; anti-PD-…